Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1990 1
1991 1
1992 1
1993 1
1994 3
1995 5
1996 2
1998 2
1999 2
2000 2
2001 2
2002 1
2003 2
2005 2
2009 3
2010 4
2011 1
2012 3
2013 2
2015 2
2016 4
2017 2
2018 4
2019 5
2020 4
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

62 results
Results by year
Filters applied: . Clear all
Page 1
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial.
Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT; Anti-TNF Therapy Against Congestive Heart Failure Investigators. Chung ES, et al. Among authors: fasanmade aa. Circulation. 2003 Jul 1;107(25):3133-40. doi: 10.1161/01.CIR.0000077913.60364.D2. Epub 2003 Jun 9. Circulation. 2003. PMID: 12796126 Clinical Trial.
Co-administration of prazosin and propranolol with glibenclamide improves anti-oxidant defense system in endothelial tissue of streptozotocin-induced diabetic Wistar rats.
Sanusi KO, Asiwe JN, Adagbada EO, Yusuf MO, Okonofua DE, Alawode DI, Fasanmade AA. Sanusi KO, et al. Among authors: fasanmade aa. J Basic Clin Physiol Pharmacol. 2020 Jun 9:/j/jbcpp.ahead-of-print/jbcpp-2019-0307/jbcpp-2019-0307.xml. doi: 10.1515/JBCPP-2019-0307. Online ahead of print. J Basic Clin Physiol Pharmacol. 2020. PMID: 32549177
62 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page